Aurinia Pharmaceuticals Inc (AUPH)

[CoolG73]

yes, this is P2 data, it shows that Hispanic and Black were a small % of the trial. in P3 you have 55% of the sites in US (Black, White, Hispanic), South America (Hispanic), Spain (Hispanic), South Africa (Black); this is a clear indication that the Black and Hispanic races will form a major part of the P3 trial; I said I am expecting around 50% because this is aligned with previous global trials done by others